Approval · Notice of Compliance 32649 · 2024
AVAXIM: Notice of Compliance 32649
Issued February 2, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32649
- Date
- February 2, 2024
- Company
- Sanofi Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVAXIM | Not yet assigned | — |
Medicinal ingredients
- HEPATITIS A VIRUS, INACTIVATED 160 UNIT per 0.5ML